Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Treasury Shares (2017 - 2025)

Marimed has reported Treasury Shares over the past 2 years, most recently at $545000.0 for Q2 2018.

  • Quarterly Treasury Shares changed N/A to $545000.0 in Q2 2018 from the year-ago period, while the trailing twelve-month figure was $545000.0 through Jun 2018, changed N/A year-over-year, with the annual reading at $45000.0 for FY2017, N/A changed from the prior year.
  • Treasury Shares was $9.9 million for Q4 2025 at Marimed, up from $8.5 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $545000.0 in Q2 2018 and troughed at -$45000.0 in Q3 2017.
  • The 5-year median for Treasury Shares is $5.7 million (2024), against an average of $5.6 million.
  • Year-over-year, Treasury Shares crashed 80.33% in 2021 and then skyrocketed 1904.63% in 2022.
  • A 2-year view of Treasury Shares shows it stood at $45000.0 in 2017, then soared by 1111.11% to $545000.0 in 2018.
  • Per Business Quant, the three most recent readings for MRMD's Treasury Shares are $9.9 million (Q4 2025), $8.5 million (Q3 2025), and $10.6 million (Q2 2025).